NewsPositive Results from Moderna's Mid-Stage Trial By InvestLuck December 14, 2023 1 Mins read Moderna Inc.’s stock (MRNA) experienced a significant surge of 7% early on Thursday, following the announcement of encouraging data from a mid-stage… Read more
